AGTC CEO to Present at Piper Jaffray Healthcare Conference on December 3, 2014
November 25, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Announces Financial Results for the First Quarter Ended September 30, 2014
November 12, 2014 16:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC to Present at Upcoming Conferences
November 10, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
Data Published in Human Gene Therapy Clinical Development Support Safety of AGTC's AAV Vector Manufacturing Process
November 03, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC President and CEO Sue Washer Receives OIS@AAO Innovator Award
October 16, 2014 09:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., and CHICAGO, Oct. 16, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus...
AGTC Named BioFlorida Company of the Year
October 14, 2014 13:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and FORT LAUDERDALE, Fla., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing...
AGTC CEO to Participate in Panel Discussions at Upcoming Conferences
October 09, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Leadership to Present at Upcoming Healthcare Conferences
September 29, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Announces Financial Results for the Quarter and Fiscal Year Ended June 30, 2014
September 26, 2014 16:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Sept. 26, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC to Participate in Emerging Ophthalmology Therapies Panel at Citi 9th Annual Biotech Conference
August 26, 2014 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Aug. 26, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical-stage biotechnology company developing adeno-associated virus (AAV)-based gene...